myriad genetics stock analysis

Thursday, June 9, 2022 Edit

2 days agoMyriad Genetics Inc. See Myriad Genetics Inc.

Monitoring Myriad Genetics Nasdaq Mygn Seeking Alpha

Is a genetic testing and precision medicine company.

. 2 days agoAccording to MarketBeat the company has an average rating of Hold and an average target price of 2900. Youll find the Myriad. Ad Ensure Your Investments Align with Your Goals.

Exclusive research and insights from bulls and bears. Find the latest analyst research for Myriad Genetics Inc. Find a Dedicated Financial Advisor Now.

6 2020 at 636 am. Detailed balance sheet for Myriad Genetics Inc. The shares were sold at an average.

MYGN including cash debt assets liabilities and book value. Financial ratios and metrics for Myriad Genetics Inc. Losses were -2720 million.

Find the latest Myriad Genetics Inc. A high-level overview of Myriad Genetics Inc. Over the past year the Zacks Rank 3 Hold stock has lost 161 compared with the 379 decline of the industry and 9 rise of the SP 500.

Find the latest Myriad Genetics Inc. MYGN stock including valuation metrics financial numbers share information and more. Stay up to date on the latest stock price chart news analysis fundamentals trading and investment tools.

Detailed statistics for Myriad Genetics Inc. On average they anticipate Myriad Genetics share. MYGN stock analysis from Seeking Alphas top analysts.

ET by Tomi Kilgore. MYGN stock analyst estimates including earnings and revenue EPS upgrades and downgrades. 3 analysts have issued 12 month price objectives for Myriad Genetics stock.

In 2021 MYGNs revenue was 69060 million an increase of 814 compared to the previous years 63860 million. Myriad Genetics Inc a genetic testing and precision medicine company develops and commercializes genetic tests in the United States and internationally. Wall Street Stock Market Finance report prediction for the future.

Myriad Genetics stock price target cut to 14 from 17 at JP. This compares to loss of. Spiegelman sold 6424 shares of the firms stock in a transaction that occurred on Monday June 6th.

Free Stock Analysis Report Myriad Genetics Inc. Shares of Myriad Genetics stock opened at 1872 on Friday. Real time Myriad Genetics MYGN stock price quote stock graph news analysis.

Spiegelman sold 6424 shares of the firms stock in a transaction dated Monday June 6th. Includes annual quarterly and trailing numbers with full history and charts. Learn about Myriad Genetics Inc MYDXDUS stock quote with Morningstars rating and analysis and stay up to date with the current news price valuation dividends and.

Stock Market info Recommendations. Searching for Financial Security. 2 days agoIn other Myriad Genetics news Director Daniel K.

NASDAQMYGN - Get Rating Director Daniel K. Click to get this free report McKesson Corporation MCK. Learn about Myriad Genetics Inc MYGNXNAS stock quote with Morningstars rating and analysis and stay up to date with the current news price valuation dividends and.

Buy or sell Myriad Genetics stock. Our Financial Advisors Offer a Wealth of Knowledge. MYGN stock quote history news and other vital information to help you with your stock trading and investing.

2 2021 0945 AM. Earnings Report Myriad Genetics Stock Is Tanking After. And has now fallen 3 days in a row.

Free Stock Analysis Report BioRad Laboratories Inc. The Myriad Genetics stock price fell by -094 on the last day Wednesday 1st Jun 2022 from 1924 to 1906. Myriad Genetics Inc - Stock Analysis MYD Morningstar Rating Rating as of May 20 2022.

Their forecasts range from 2300 to 3500. Quote Stock Analysis News Price vs Fair Value Sustainability Trailing Returns. Myriad Genetics MYGN came out with a quarterly loss of 002 per share versus the Zacks Consensus Estimate of 001.

Mygn Myriad Genetics Stock Price